Effective treatment of a peripheral T-cell lymphoma/lymphoepitheloid cell variant (Lennert's lymphoma) refractory to chemotherapy with the CD-52 antibody alemtuzumab.

Saved in:
Bibliographic Details
Title: Effective treatment of a peripheral T-cell lymphoma/lymphoepitheloid cell variant (Lennert's lymphoma) refractory to chemotherapy with the CD-52 antibody alemtuzumab.
Authors: Zeitlinger, M. A.1,2, Schmidinger, M.1, Zielinski, C. C.1,3, Chott, A.4, Raderer, M.1,3 markus.raderer@meduniwien.ac.at
Source: Leukemia & Lymphoma. May2005, Vol. 46 Issue 5, p771-774. 4p.
Database: Academic Search Ultimate
Description
ISSN:10428194
DOI:10.1080/10428190400028959